We are live on ! Find out more
EC

Eleva Capital Portfolio holdings

AUM $343M
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$343M
AUM Growth
$0
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
97.63%
Holding
24
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Materials 81.31%
2 Technology 6.21%
3 Communication Services 6.04%
4 Consumer Discretionary 4.34%
5 Healthcare 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRH icon
1
CRH
CRH
$63B
$279M 81.27%
2,654,974
– –
AS icon
2
Amer Sports
AS
$19.8B
$9.84M 2.86%
298,802
– –
NVDA icon
3
NVIDIA
NVDA
$5.25T
$9.07M 2.64%
52,002
– –
NFLX icon
4
Netflix
NFLX
$334B
$8.38M 2.44%
87,190
– –
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.17T
$8.04M 2.34%
27,967
– –
TSM icon
6
TSMC
TSM
$2.16T
$6.51M 1.89%
21,411
– –
ANET icon
7
Arista Networks
ANET
$232B
$5.77M 1.68%
46,957
– –
AMZN icon
8
Amazon
AMZN
$2.81T
$3.36M 0.98%
16,155
– –
TMUS icon
9
T-Mobile US
TMUS
$196B
$3.01M 0.88%
14,347
– –
HOOD icon
10
Robinhood
HOOD
$85.5B
$2.19M 0.64%
31,625
– –
ONON icon
11
On Holding
ONON
$9.99B
$1.71M 0.5%
50,150
– –
BSX icon
12
Boston Scientific
BSX
$71.5B
$1.67M 0.49%
26,667
– –
SPOT icon
13
Spotify
SPOT
$110B
$1.32M 0.38%
2,715
– –
NAMS icon
14
NewAmsterdam Pharma
NAMS
$3.41B
$823K 0.24%
25,721
– –
CGON icon
15
CG Oncology
CGON
$7.15B
$561K 0.16%
8,289
– –
ESPR
16
DELISTED
Esperion Therapeutics
ESPR
$502K 0.15%
183,047
– –
MLYS icon
17
Mineralys Therapeutics
MLYS
$2.38B
$463K 0.13%
17,081
– –
FENC icon
18
Fennec Pharmaceuticals
FENC
$416M
$327K 0.1%
53,234
– –
IRON icon
19
Disc Medicine
IRON
$3.08B
$327K 0.1%
5,115
– –
VRDN icon
20
Viridian Therapeutics
VRDN
$2.78B
$139K 0.04%
7,126
– –
FCX icon
21
Freeport-McMoran
FCX
$99.7B
$133K 0.04%
2,258
– –
ACHR icon
22
Archer Aviation
ACHR
$4.69B
$111K 0.03%
21,534
– –
EWTX icon
23
Edgewise Therapeutics
EWTX
$5.04B
$55K 0.02%
17,460
– –
AQST icon
24
Aquestive Therapeutics
AQST
$576M
$11.3K ﹤0.01%
2,720
– –

Similar funds

CP
Capital Planning Bellevue, Washington $343M AUM 19.13% 1-Year Est. Return
QWM
Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return
HPC
Highland Peak Capital Old Greenwich, Connecticut $344M AUM 141.35% 1-Year Est. Return
PA
PFW Advisors Atlanta, Georgia $343M AUM 18.74% 1-Year Est. Return
WA
Wealthstar Advisors Plano, Texas $343M AUM 49.94% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
OIC
Orion Investment Company St. Louis, Missouri $343M AUM 52.59% 1-Year Est. Return
SP
Saranac Partners London $343M AUM 11.5% 1-Year Est. Return

Eleva Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Eleva Capital held 24 positions worth $343M, unchanged from the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Eleva Capital opened no new positions and made no exits, leaving the 24-position portfolio largely intact.

By sector, the portfolio is most concentrated in Materials at 81% of assets, unchanged from a quarter earlier, followed by Technology and Communication Services.

  • Eleva Capital's ten largest holdings make up 98% of its $343M portfolio in Q2 2026.
  • Eleva Capital opened 0 new positions and closed 0 in Q2 2026.
  • Eleva Capital's portfolio value was unchanged quarter-over-quarter at $343M.

Based on Eleva Capital's 13F filing for Q2 2026, filed 2 Jul 2026.